Wealth Alliance Advisory Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08M Buy
5,753
+2
+0% +$685 0.3% 57
2026
Q1
$2.02M Buy
5,751
+19
+0.3% +$6.77K 0.32% 58
2025
Q4
$1.88M Sell
5,732
-59
-1% -$18.7K 0.32% 57
2025
Q3
$1.63M Sell
5,791
-372
-6% -$108K 0.29% 60
2025
Q2
$1.72M Buy
6,163
+160
+3% +$45.3K 0.33% 57
2025
Q1
$1.87M Sell
6,003
-586
-9% -$173K 0.39% 49
2024
Q4
$1.72M Buy
6,589
+16
+0.2% +$4.75K 0.36% 51
2024
Q3
$2.12M Buy
6,573
+38
+0.6% +$12.4K 0.44% 44
2024
Q2
$2.04M Sell
6,535
-137
-2% -$40.2K 0.46% 43
2024
Q1
$1.9M Buy
6,672
+321
+5% +$93.9K 0.44% 44
2023
Q4
$1.83M Sell
6,351
-9
-0.1% -$2.45K 0.48% 42
2023
Q3
$1.71M Sell
6,360
-341
-5% -$85.1K 0.51% 37
2023
Q2
$1.49M Buy
6,701
+88
+1% +$20.4K 0.53% 37
2023
Q1
$1.6M Buy
6,613
+1,021
+18% +$251K 0.6% 34
2022
Q4
$1.47M Buy
5,592
+260
+5% +$69.7K 0.56% 35
2022
Q3
$1.2M Buy
5,332
+739
+16% +$179K 0.53% 37
2022
Q2
$1.12M Hold
4,593
0.53% 35
2022
Q1
$1.11M Sell
4,593
-18
-0.4% -$4.14K 0.48% 37
2021
Q4
$1.04M Sell
4,611
-175
-4% -$36.9K 0.45% 39
2021
Q3
$1.02M Buy
4,786
+19
+0.4% +$4.37K 0.49% 39
2021
Q2
$1.16M Buy
4,767
+42
+0.9% +$10.3K 0.57% 34
2021
Q1
$1.18M Sell
4,725
-196
-4% -$46.8K 0.6% 33
2020
Q4
$1.13M Buy
4,921
+94
+2% +$21.7K 0.61% 32
2020
Q3
$1.23M Sell
4,827
-14
-0.3% -$3.47K 0.73% 26
2020
Q2
$1.14M Hold
4,841
0.7% 29
2020
Q1
$981K Buy
4,841
+15
+0.3% +$3.28K 0.76% 30
2019
Q4
$1.16M Buy
4,826
+100
+2% +$22K 0.66% 30
2019
Q3
$949K Hold
4,726
0.59% 32
2019
Q2
$832K Hold
4,726
0.51% 39
2019
Q1
$822K Hold
4,726
0.53% 36
2018
Q4
$920K Sell
4,726
-1,007
-18% -$196K 0.69% 33
2018
Q3
$1.19M Hold
5,733
0.61% 37
2018
Q2
$1.06M Buy
5,733
+1,339
+30% +$237K 0.58% 36
2018
Q1
$749K Buy
4,394
+2,350
+115% +$431K 0.44% 46
2017
Q4
$355K Buy
+2,044
New +$362K 0.32% 64

Other funds holding AMGN

Wealth Alliance Advisory Group's AMGN Position: Q2 2026 in Review

Wealth Alliance Advisory Group increased its Amgen (AMGN) stake by 0.03% in Q2 2026, buying an estimated $685 and bringing the position to 5,753 shares worth $2.08M. The position accounts for 0.3% of the portfolio, ranked #57.

Wealth Alliance Advisory Group first reported a position in AMGN in Q4 2017 and has held it in 35 quarters since. The position peaked at $2.12M in Q3 2024. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Wealth Alliance Advisory Group held 5,753 shares of Amgen worth $2.08M as of Q2 2026.
  • Wealth Alliance Advisory Group bought 2 Amgen shares in Q2 2026, an estimated $685.
  • Amgen made up 0.3% of Wealth Alliance Advisory Group's portfolio in Q2 2026, its #57 holding.
  • Wealth Alliance Advisory Group first reported a position in Amgen in Q4 2017 and has held it in 35 quarters since.
  • Wealth Alliance Advisory Group's Amgen position peaked at $2.12M in Q3 2024.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Wealth Alliance Advisory Group's 13F filing for Q2 2026, filed 23 Jul 2026.